How to choose sample handling and liquid handling equipment

From benchtop pipette to full robotic cell: what lab managers, procurement officers, and biomed engineers need to know before signing a PO.

What this is and who buys it

Sample handling equipment covers the full spectrum of tools used to move, measure, dilute, transfer, and aliquot biological and chemical samples in a controlled, reproducible way. At the simple end that means a calibrated multi-channel manual pipette; at the complex end, a fully integrated robotic cell with plate hotels, barcode readers, thermal nests, HEPA filtration, and a scheduling layer that can run unattended overnight. The broad middle ground — semi-automated benchtop liquid handlers and modular workstations — is where most procurement decisions land.

Buyers span a wide range of settings: genomics core facilities running NGS library prep at scale, hospital and reference labs processing thousands of nucleic acid extractions per week, pharmaceutical screening groups transferring nanoliter compound volumes to 384- or 1,536-well plates, and academic labs building out automation for the first time on a constrained budget. What they share is a need to reduce pipetting variability, protect expensive samples, and generate audit-ready records — whether to satisfy ISO 17025, GxP, or CLIA requirements.

The category gained urgency after 2020. The SARS-CoV-2 pandemic exposed the fragility of manual high-throughput sample processing and accelerated adoption of mid-tier robotic platforms in clinical and public-health labs that had previously relied entirely on manual pipetting. That institutional memory hasn't faded, and procurement teams are now evaluating automation more systematically than before.

Key decision factors

Pipetting technology and liquid-class compatibility is the starting point, not an afterthought. Air-displacement pipetting uses an air cushion to transmit force and works well across a broad viscosity range. Positive-displacement pipetting uses a piston in direct contact with the liquid — the right choice for volatile solvents like DMSO, viscous materials like glycerol, DNA samples where aerosol contamination is a concern, and dosing volumes below 0.5 µL. Accuracy specs published for water don't automatically translate to aqueous polymer solutions or cell suspensions, so performance data must be generated with your actual liquid classes.

Channel configuration and throughput should be matched to actual daily plate volume, not theoretical peak demand. Heads range from single-channel to 96-channel, 384-channel, and up to 1,536-channel formats for specialized screening platforms. A 96-channel head dramatically reduces cycle time for full-plate reformatting but represents significant capital overhead if you're processing 20 plates a day. Work backward from real sample numbers before evaluating any specific platform.

Working volume range and accuracy at low volumes is where meaningful differentiation exists. Standard 96-channel robotic heads on many mid-tier workstations pipette between 1 and 1,000 µL, though some configurations top out at 200 µL [S7]. For nanoliter-range work — sub-microliter compound transfers in drug discovery — acoustic dispensers and positive-displacement nanodispensers represent an entirely different technology category requiring separate evaluation criteria.

Deck modularity and integration capability determines whether your investment ages well or becomes a workflow island. Most robotic pipettors support on-deck shakers, heating/cooling nests, magnetic-bead stations, and filtration manifolds. What matters at procurement is confirming expansion slots, third-party device driver availability, and validated LIMS integration via a documented API. Request the software development kit documentation before the application demo.

Software compliance and scripting complexity diverge meaningfully across platforms. Regulated environments — GxP manufacturing, CLIA-certified labs, FDA-registered IVD workflows — require 21 CFR Part 11-compliant software with audit trails, electronic signatures, and role-based user access controls. Programming complexity also affects time-to-deployment: some platforms use modular GUI-based scripting an experienced scientist can learn in a week; others require dedicated automation engineers and have build-to-order lead times exceeding six months. Neither is inherently superior, but the configurability-versus-time-to